Although metformin exerts its therapeutic effect mainly by reducing hepatic glucose production, it also reduces DPP-4 activity and increases GLP-1 secretion, which may be significant in the current context [ 31 ].
← all excerpts
Effect of pasireotide on glucose- and growth hormone-related biomarkers in patients with inadequately controlled acromegaly.
1
—
—